
Coloplast has had its recommendation lowered to "sell" from "hold" by the investment bank ABG Sundal Collier.
The share price target has also been lowered to DKK 900 (USD 140) from DKK 1141 (USD 177).
Already a subscriber? Log in.
Read the whole article
Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
- Access all locked articles
- Receive our daily newsletters
- Access our app